| Deirdre L Courtney, AUD | |
|
7845 Oakwood Rd, Glen Burnie, MD 21061-4280 | |
| (107) 604-3274 | |
| (866) 253-2466 |
| Full Name | Deirdre L Courtney |
|---|---|
| Gender | Female |
| Speciality | Qualified Audiologist |
| Experience | 10 Years |
| Location | 7845 Oakwood Rd, Glen Burnie, Maryland |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1851704779 | NPI | - | NPPES |
| 01322 | Other | MD | LICENSE |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 231HA2400X | Audiologist - Assistive Technology Practitioner | 01322 (Maryland) | Secondary |
| 231H00000X | Audiologist | 01322 (Maryland) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| The Hearing Wellness Center Llc | 4183036593 | 2 |
News Archive
DOR BioPharma, Inc. (DOR or the Company) (OTC Bulletin Board: DORB), a late-stage biotechnology company, announced today that it has entered into common stock purchase agreements with institutional investors totaling approximately $3.85 million. DOR's North American commercial partner, Sigma-Tau Pharmaceuticals, Inc., participated in this financing.
Through the study of the roundworm, Caenorhabditis elegans, the team led by Hugo Aguilaniu has discovered a hormone that enhances longevity and reduces fertility, thus reproducing the effects of an extreme diet.
Non-invasive imaging detects prostate cancer earlier than ever before, but can't accurately distinguish between malignant and benign disease. According to Lawson Health Research Institute's Drs. John Lewis and Len Luyt, a new molecular imaging probe could be the answer.
New research by scientists at the University of Cambridge suggests that chronic cocaine abuse accelerates the process of brain ageing. The study, published today 25 April in Molecular Psychiatry, found that age-related loss of grey matter in the brain is greater in people who are dependent on cocaine than in the healthy population.
Genomic Health, Inc. today announced positive preliminary results from a study of Oncotype DX in patients with DCIS by the Eastern Cooperative Oncology Group, a clinical trials cooperative group supported by the National Cancer Institute.
› Verified 5 days ago
| Provider Name | Audiology Associates Inc. |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1942325527 PECOS PAC ID: 4981626389 Enrollment ID: O20051229000228 |
News Archive
DOR BioPharma, Inc. (DOR or the Company) (OTC Bulletin Board: DORB), a late-stage biotechnology company, announced today that it has entered into common stock purchase agreements with institutional investors totaling approximately $3.85 million. DOR's North American commercial partner, Sigma-Tau Pharmaceuticals, Inc., participated in this financing.
Through the study of the roundworm, Caenorhabditis elegans, the team led by Hugo Aguilaniu has discovered a hormone that enhances longevity and reduces fertility, thus reproducing the effects of an extreme diet.
Non-invasive imaging detects prostate cancer earlier than ever before, but can't accurately distinguish between malignant and benign disease. According to Lawson Health Research Institute's Drs. John Lewis and Len Luyt, a new molecular imaging probe could be the answer.
New research by scientists at the University of Cambridge suggests that chronic cocaine abuse accelerates the process of brain ageing. The study, published today 25 April in Molecular Psychiatry, found that age-related loss of grey matter in the brain is greater in people who are dependent on cocaine than in the healthy population.
Genomic Health, Inc. today announced positive preliminary results from a study of Oncotype DX in patients with DCIS by the Eastern Cooperative Oncology Group, a clinical trials cooperative group supported by the National Cancer Institute.
› Verified 5 days ago
| Provider Name | The Hearing And Speech Agency |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1083706725 PECOS PAC ID: 2860537941 Enrollment ID: O20100301000157 |
News Archive
DOR BioPharma, Inc. (DOR or the Company) (OTC Bulletin Board: DORB), a late-stage biotechnology company, announced today that it has entered into common stock purchase agreements with institutional investors totaling approximately $3.85 million. DOR's North American commercial partner, Sigma-Tau Pharmaceuticals, Inc., participated in this financing.
Through the study of the roundworm, Caenorhabditis elegans, the team led by Hugo Aguilaniu has discovered a hormone that enhances longevity and reduces fertility, thus reproducing the effects of an extreme diet.
Non-invasive imaging detects prostate cancer earlier than ever before, but can't accurately distinguish between malignant and benign disease. According to Lawson Health Research Institute's Drs. John Lewis and Len Luyt, a new molecular imaging probe could be the answer.
New research by scientists at the University of Cambridge suggests that chronic cocaine abuse accelerates the process of brain ageing. The study, published today 25 April in Molecular Psychiatry, found that age-related loss of grey matter in the brain is greater in people who are dependent on cocaine than in the healthy population.
Genomic Health, Inc. today announced positive preliminary results from a study of Oncotype DX in patients with DCIS by the Eastern Cooperative Oncology Group, a clinical trials cooperative group supported by the National Cancer Institute.
› Verified 5 days ago
| Provider Name | The Hearing Wellness Center Llc |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1972105302 PECOS PAC ID: 4183036593 Enrollment ID: O20201209000045 |
News Archive
DOR BioPharma, Inc. (DOR or the Company) (OTC Bulletin Board: DORB), a late-stage biotechnology company, announced today that it has entered into common stock purchase agreements with institutional investors totaling approximately $3.85 million. DOR's North American commercial partner, Sigma-Tau Pharmaceuticals, Inc., participated in this financing.
Through the study of the roundworm, Caenorhabditis elegans, the team led by Hugo Aguilaniu has discovered a hormone that enhances longevity and reduces fertility, thus reproducing the effects of an extreme diet.
Non-invasive imaging detects prostate cancer earlier than ever before, but can't accurately distinguish between malignant and benign disease. According to Lawson Health Research Institute's Drs. John Lewis and Len Luyt, a new molecular imaging probe could be the answer.
New research by scientists at the University of Cambridge suggests that chronic cocaine abuse accelerates the process of brain ageing. The study, published today 25 April in Molecular Psychiatry, found that age-related loss of grey matter in the brain is greater in people who are dependent on cocaine than in the healthy population.
Genomic Health, Inc. today announced positive preliminary results from a study of Oncotype DX in patients with DCIS by the Eastern Cooperative Oncology Group, a clinical trials cooperative group supported by the National Cancer Institute.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Deirdre L Courtney, AUD 3615 E Joppa Rd Ste 210, Parkville, MD 21234-3386 Ph: (410) 944-3100 | Deirdre L Courtney, AUD 7845 Oakwood Rd, Glen Burnie, MD 21061-4280 Ph: (107) 604-3274 |
News Archive
DOR BioPharma, Inc. (DOR or the Company) (OTC Bulletin Board: DORB), a late-stage biotechnology company, announced today that it has entered into common stock purchase agreements with institutional investors totaling approximately $3.85 million. DOR's North American commercial partner, Sigma-Tau Pharmaceuticals, Inc., participated in this financing.
Through the study of the roundworm, Caenorhabditis elegans, the team led by Hugo Aguilaniu has discovered a hormone that enhances longevity and reduces fertility, thus reproducing the effects of an extreme diet.
Non-invasive imaging detects prostate cancer earlier than ever before, but can't accurately distinguish between malignant and benign disease. According to Lawson Health Research Institute's Drs. John Lewis and Len Luyt, a new molecular imaging probe could be the answer.
New research by scientists at the University of Cambridge suggests that chronic cocaine abuse accelerates the process of brain ageing. The study, published today 25 April in Molecular Psychiatry, found that age-related loss of grey matter in the brain is greater in people who are dependent on cocaine than in the healthy population.
Genomic Health, Inc. today announced positive preliminary results from a study of Oncotype DX in patients with DCIS by the Eastern Cooperative Oncology Group, a clinical trials cooperative group supported by the National Cancer Institute.
› Verified 5 days ago
Anne Arundel Audiology Llc Audiologist Medicare: Medicare Enrolled Practice Location: 1600 Crain Hwy S Ste 509, Glen Burnie, MD 21061 Phone: 410-766-6320 Fax: 410-755-8766 | |
Logan H Fraser, AU.D. Audiologist Medicare: Medicare Enrolled Practice Location: 7845 Oakwood Rd Ste 303, Glen Burnie, MD 21061 Phone: 410-760-4327 Fax: 866-655-8181 | |
Stephen B Pallett, AU.D. Audiologist Medicare: Not Enrolled in Medicare Practice Location: 203 Hospital Dr, Ste 200, Glen Burnie, MD 21061 Phone: 410-760-8840 | |
Jennifer Marie Hutchison, AU.D. Audiologist Medicare: Not Enrolled in Medicare Practice Location: 203 Hospital Dr, Suite 200, Glen Burnie, MD 21061 Phone: 410-760-8840 | |
Monica Ann Davis, AU.D. Audiologist Medicare: Accepting Medicare Assignments Practice Location: 203 Hospital Dr, Suite 200, Glen Burnie, MD 21061 Phone: 410-760-8840 Fax: 410-760-8847 | |
Bls Diagnostics Llc Audiologist Medicare: Not Enrolled in Medicare Practice Location: 7704 Quarterfield Rd Ste I, Glen Burnie, MD 21061 Phone: 866-526-8088 | |
Gretchen M Paige, Audiologist Medicare: Accepting Medicare Assignments Practice Location: 203 Hospital Dr, Ste 200, Glen Burnie, MD 21061 Phone: 410-760-8840 |